CIO Bulletin

Technologically advanced MedTech Robotics solutions delivering high-quality medical attention to patients: XACT Robotics

Robotics is gaining importance in every sphere of our life. Healthcare sector is also seeing an increase in technologies that depend on robotics. Robotics in healthcare has the ability to transform work practices and save lives and also increase the levels of safety. Globally, there are various companies providing excellent services in the MedTech robotics space, among them, XACT Robotics stands out. XACT Robotics^®is a privately held company focused on advancing the field of radiology by developing the world’s first and only hands-free robotic solutions that can significantly improve targeting accuracy, efficiency, and consistency in percutaneous radiology procedures. The company was founded in 2013 by Harel Gadot, a renowned entrepreneur in the MedTech robotics space, whose vision reimagined how image-guided percutaneous procedures are performed.

XACT embraces the philosophy of collaboration, tenacity, and extreme ownership. The company’s family culture empowers and inspires as it partners, develops, and executes meaningful technologies to make a difference in the lives of patients. XACT Robotics’ leadership is comprised of start-up, robotic, and disruptive technology experts with deep knowledge, vast experience and the diverse leadership skills required in the robotic market. The XACT ACE^™ Robotic System is the world’s first and only hands-free robotic technology that combines advanced image-based procedure planning and navigation with robotic instrument insertion and non-linear steering capabilities.

Accuracy

The XACT ACE^™ Robotic system (ACE) provides hands-free targeting with a high level of accuracy and control, to enable performing a wide variety of percutaneous procedures, including biopsies, ablations, and site-specific drug delivery. By combining image-based planning and navigation with robotic instrument insertion and non-linear steering capabilities, ACE enables users to achieve instrument tip-to-target average accuracy of < 3mm. ACE’s non-linear steering capabilities enable radiologists to access hard-to-reach locations even if the target moves during the procedure due to instrument insertion or patient movement or breathing.

Consistency

By optimizing accuracy, ACE can lead to more predictable and consistent procedure times and enhanced patient outcomes. With its highly consistent and reproducible one-insertion-to-target performance, ACE minimizes the need for and incidence of instrument reinsertions, reducing procedure complexities, delays and duration. In clinical studies, ACE’s hands-free robotic skin to target time was < 8.5 minutes on average. This enables predictable procedure duration that enhances the utilization of healthcare facilities and staff.

Efficiency

The XACT ACE^™Robotic System has a small footprint; it is compact and portable and enables care providers to efficiently treat a broad range of patient care needs across multiple areas of the body. ACE can be set up for use with patients within minutes and does not require a specialized, dedicated operating space. ACE is capable of delivering various instruments to a desired target for a wide variety of percutaneous procedures, such as ablation, biopsy and drug delivery, and is designed to be compatible with multiple imaging modalities.

The XACT ACE^® Robotic System received US Food and Drug Administration (FDA) clearance for a modification to its cleared XACT ACE^® Robotic System designed to support robotic insertion and steering of ablation probes during ablation clinical procedures. This clearance expands the company’s already broad indication for CT-guided percutaneous procedures with over 200 clinical cases performed to date in multiple medical centers. “Ablation procedures are challenging to many users in terms of the accuracy and time required to place the ablation probes” said Harel Gadot, founder and executive chairman of XACT Robotics^®. “The proven ability of the company’s system to reach relatively small targets, regardless of target movement or obstacles, with unparalleled accuracy and one insertion to target will provide better patient outcomes with greater efficiencies. Moreover, with the addition of the newly cleared ablation capabilities, XACT Robotics can now provide even more value to its partners by increasing the utilization of its system.”

The comprehensive XACT ACE^® Robotic System is the first and only technology that combines image-based procedure planning and real time monitoring with hands free precise robotic insertion and non-linear steering. Using the XACT ACE^® Robotic System for ablation probe insertion and steering, health systems now have the potential to save time with fast and accurate probe placement, contributing to the overall procedure efficiency and success. The proprietary robotic insertion and non-linear steering precisely delivers instruments to a desired target in the body—overcoming the size, depth, movement, or obstructions that may be in the path. The system has been proven to achieve unparalleled 1.7mm tip to target average accuracy upon first insertion, with a less than 8.5-minute average skin to target time. This has the potential to enhance a user’s ability to provide more timely and accurate diagnoses and treatment for patients, helping to reduce the “watchful waiting” period and improve outcomes.

Meet the Leader

Shai Meltzer, Chief Executive Officer of XACT Robotics. Shai is a well-established executive with more than 20 years of management experience, which includes finance and accounting, developing business growth strategies, maximizing operating margins as well as building strong, diverse teams. Prior to joining XACT, Shai was Head of Finance for Marvell Israel. Before this, Shai was the CFO at Wavion Networks. Most recently, Shai held a few key positions at Nanomotion, starting as CFO, VP Operations and then followed by a General Manager position. Shai holds a B.A. in Economics and Accounting from Haifa University, Israel.